Glaxosmithkline PLC ADR Equity

Glaxosmithkline PLC ADR Equity is a security (CUSIP 37733W105) tracked across SEC portfolio filings. 5 institutional managers reported $128K on Form 13F as of 2026-06-30; 2 registered fund positions totaling $3.9M via N-PORT as of 2021-09-30.

Summary

Issuer: Glaxosmithkline PLC ADR
Class: Equity
CUSIP: 37733W105
Asset category: EC
13F holders: 5
13F value: $128K
13F period: 2026-06-30
N-PORT fund positions: 2
N-PORT value: $3.9M
N-PORT report: 2021-09-30

Top institutional holders (Form 13F)

Manager	Location	Value	Shares
Cascades Capital Asset Management, LLC	GREENSBORO, NC	$104K	1,888
Asset Planning,Inc	LOS ALAMITOS, CA	$14K	264
HORIZON FINANCIAL SERVICES, LLC	WINSTON SALEM, NC	$7K	129
Byrne Asset Management LLC	KINGSTON, NJ	$3K	56
HUNTINGTON NATIONAL BANK	COLUMBUS, OH	$40	1

Top fund holders (N-PORT)

Fund	Registrant	Value	% of fund
Nuveen Tax-Advantaged Total Return Strategy Fund	Nuveen Tax-Advantaged Total Return Strategy Fund	$2.6M	156.58%
Nuveen Diversified Dividend and Income Fund	Nuveen Diversified Dividend and Income Fund	$1.3M	58.48%

More